Smedvig logo

Smedvig

Europe, Rogaland, Norway, Stavanger

Description

The history of the Smedvig family’s operations demonstrates an excellent track record in managing businesses.

Investor Profile

Smedvig has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Undisclosed (50%)

Country Focus

  • Belgium (50%)
  • South Africa (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Mining
  • Precious Metals
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Smedvig frequently co-invest with?

6V
Europe, Hainaut, Belgium, Charleroi
Co-Investments: 1
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 1
Co-Investments: 1
Mérieux Equity Partners
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1

Which angels does Smedvig often collaborate with?

KB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Smedvig?

Sedibelo Resources

Centurion, NA - South Africa, South Africa

Sedibelo Resources is a developing producer of platinum group metals (PGMs), is active in the acquisition, exploration.

MiningPrecious Metals
UndisclosedMar 7, 2025
Amount Raised: $3,000,000
Amyl Therapeutics

Liège, Liege, Belgium

Amyl Therapeutics is a preclinical stage biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series AJun 3, 2021
Amount Raised: $10,432,525